Trials / Unknown
UnknownNCT04118647
Effective Mechanisms of Wu-Chu-Yu Tang on Gastroesophageal Disorder
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 55 (estimated)
- Sponsor
- China Medical University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Gastroesophageal reflux disorder (GERD) is due to gastric content reflux to esophagus cause symptom and complication including intra-esophagus such as reflux esophagitis, and extra-esophagus such as cough etc. Because the changes of dietary habit, and improvement of examination skill and data analysis, the prevalence of GERD increased 2.5 multiple from 1995 to 2002, and suggesting the prevalence is 25% in Taiwan community. The etiology of GERD is multi-effect, such as transient lower esophageal sphincter relaxation and abnormal pressure of lower esophageal sphincter, which may induced the esophageal mucosal injury by gastric acid, bile or pancreases enzyme. Wu-Chu-Yu tang consists of Evodia fargesii Dode (Evodia Fruit), Panax ginseng C. (Ginseng), Ziziphus jujube Mill (Chinses Date), Zingiber officinale Rosee (Fresh Ginger).According to "I-Fang-Chi-Chieh" and "Shanghonzobinglun" recordings that Wu-Chu-Yu tang can treat vomiting, and also can relax gastric tonicity and can enhance peristalsis of stomach. According to Randomized, double blind, placebo control trial to evaluate the efficacy of Wu-Chu-Yu Tang on gastroesophageal reflux disease, we know the Wu-Chu-Yu tang have the equivalent effect proton pump inhibitor omeprazole. But, the mechanism of Wu-Chu-Yu tang is still unknown.
Conditions
- Wu-Chu-Yu Tang
- Gastroesophageal Reflux Disorder
- 24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Wu-Chu-Yu tang | Wu-Chu-Yu tang at a rate of 3.0 g three times per day for 28 days. |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2021-09-01
- Completion
- 2021-09-01
- First posted
- 2019-10-08
- Last updated
- 2019-10-08
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT04118647. Inclusion in this directory is not an endorsement.